Tabari Baker
scientifica sessions.
Hosted by Tabari Baker, CEO of kronos scientifica, scientifica sessions features unscripted conversations with the executives, innovators, and visionaries shaping the future of biotech, medtech, pharma, and healthtech. Each episode dives into the realities of leadership in a rapidly evolving industry: scaling medical affairs and commercial teams, building investor confidence, navigating regulatory shifts, unlocking digital health and AI, and driving commercialization strategies that matter. Guests share candid stories from the boardroom to the clinic—what worked, what didn't, and what's next....
Autor
Tabari Baker
Kategorie
Podcast-Website
Neueste Folge
28. Mai 2026
Wo hören?
Podcasts in der App Replaio Radio Bald verfügbarPodcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts
Folgen
Southern Catalyst: How Atlanta Is Building the Southeast’s Life Sciences Powerhouse 28.05.2026 1:35:24
Episode Description: Atlanta is often overlooked in the life sciences conversation—but what if that's exactly the point? In this episode of scientifica sessions, we go inside the Atlanta ecosystem to unpack how a city built on public health leadership, world-class institutions, and deep clinical infrastructure is quietly assembling one of the most strategically compelling life sciences hubs in the...
Cracking the Code: How Massachusetts Built the Most Intentional Life Sciences Ecosystem in the World 07.04.2026 59:24
Episode Description: Massachusetts is often viewed as the epicenter of biotech—but what actually makes this ecosystem work? In this episode of scientifica sessions , we go inside the Commonwealth to unpack the deliberate strategy behind one of the most successful life sciences hubs in the world. Joined by leaders from the Massachusetts Life Sciences Center (MLSC) and founders building within the e...
The Frontier Formula: Oklahoma's Blueprint for America's Next Life Sciences Hub 16.02.2026 47:33
Episode Description What if the next great American life sciences hub isn’t on the coasts—but in the heartland? In this episode of scientifica sessions , we look beyond the usual biotech strongholds to explore Oklahoma’s emergence as a new life sciences contender. While Boston and San Francisco dominate the narrative, Oklahoma is quietly building a different model—one that blends energy-sector exp...
From Concept to Capital: How Early-Stage Biotech Gets Funded with Dan Goddard 01.02.2026 45:06
Episode Description In this episode of scientifica sessions, host Tabari Baker (Founder & CEO, kronos scientifica ) sits down with Dan Goddard , Business Development Lead at CFGO , to explore one of the most critical—and misunderstood—journeys in life sciences: moving a company from concept to capital . Early-stage biotech lives at the intersection of breakthrough science, disciplined executio...
From Friction to Function: Fixing Collaboration with Patrina Pellett and Chase Wasson 15.01.2026 46:28
Episode Description In this episode of scientifica sessions, host Tabari Baker (Founder & CEO, kronos scientifica) tackles one of the most persistent—and consequential—tensions in life sciences: the complicated relationship between Medical Affairs and Commercial. Too often it’s a “love–hate” dynamic fueled by shared stakeholders, unclear roles, conflicting metrics, and leadership misalignment....
Genomics, Access, and the Human Story Behind Precision Medicine: A Conversation with Rome Madison 15.12.2025 59:34
Episode Description In this episode of scientifica sessions , we sit down with Rome Madison —founder of the Genetics for Healthcare podcast and a leading voice in genomic sales enablement and clinician education. With more than two decades of experience helping life-science organizations adopt precision medicine, Rome focuses on translating complex genomic science into practical, real-world clinic...
The Dark Side of Data: Power, Privacy, and the Pursuit of Precision with Ardy Arianpour 15.11.2025 47:53
Episode Description In this episode of s cientifica sessions , we take an unfiltered look at the complex relationship between innovation, privacy, and power in healthcare data with Ardy Arianpour , CEO and Co-Founder of SEQSTER . The life sciences industry is overflowing with data—EHRs, genomic profiles, claims data, wearables, and AI-driven predictions—but more data doesn't always mean better dec...
From Wearables to Real-World Evidence: Drew Schiller on the Future of Life Sciences 15.10.2025 1:07:31
Episode Description In this episode of scientifica sessions , we dive into the rapidly evolving world of real-world evidence (RWE) and patient-generated health data (PGHD) with Drew Schiller , Co-Founder and CEO of Validic . As life sciences companies increasingly look beyond traditional clinical trials, Drew shares how data from wearables, remote monitoring devices, and connected health platforms...
scientifica sessions: Welcome to the Conversation 15.09.2025 2:23
In this inaugural episode, host Tabari Baker, Founder & CEO of kronos scientifica, introduces Scientifica Sessions —a new podcast at the intersection of science, strategy, and commercialization. With over 15 years of leadership experience in medical affairs, clinical development, and biotech commercialization, Tabari has worked with companies navigating late-stage trials, preparing for launch,...
Generative Chemogenomics & the Future of Drug Discovery: Inside AI‑Driven R&D with Tom Neyarapally 14.09.2025 1:12:27
Episode Description What if you could screen billions of potential therapies—virtually—in the time it takes to brew your morning coffee? In this episode of scientifica sessions , host Tabari Baker sits down with Tom Neyarapally, CEO and co-founder of Archetype Therapeutics, to explore how AI-native biotech is redefining what's possible in early-stage drug discovery. With a background that spans la...
Ähnliche Podcasts
Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet